Corvus Pharmaceuticals Statistics
NASDAQ: CRVSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
10.41-0.15 (-1.42%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 10.52 +1.06%
Corvus Pharmaceuticals by the numbers
Corvus Pharmaceuticals has a market capitalization of $875.7 million based on 84.12M shares outstanding. With trailing EPS of $-0.62, Corvus Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 22.3% below its 50-day average and 26.6% below its 200-day average.
Average daily trading volume is 996.12K shares, or about $10.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CRVS valuation vs. peer median
| Metric | CRVS | Peer median | Difference |
|---|---|---|---|
| Market cap | $875.70M | $887.60M | -1% |
| Avg. volume | 996.12K | 753.51K | +32% |
Peer median across 8 companies: RIGL, CYRX, ALMS, JBIO, ANL, MLTX, ANRO, ARDX.
Valuation
- Market cap
- $875.70M
- EPS (TTM)
- $-0.62
- Shares outstanding
- 84.12M
Price and trading
- Previous close
- 10.56
- Open
- 10.25
- Day range
- 10.25 – 10.65
- 52-week range
- 6.39 – 26.95
- 52-week change
- +51.53%
- Beta
- —
- Volume
- 1.16M
- Average volume
- 996.12K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 875.70M
- Forward Pe
- -9.75
- Eps
- -0.62
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 26.95
- Week52 Low
- 6.39
- Avg Volume
- 996.12K
- Shares Outstanding
- 84.12M
- Ma50
- 13.39
- Ma200
- 14.18
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -61.37%
- Pct From52w Low
- 62.91%